Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage II melanoma-Reference-Cited by-同舟云学术

Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage II melanoma

Published:2002-12-18 Issue:1 Volume:97 Page:186-200
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Weber Jeffrey,Sondak Vernon K.,Scotland Ronaldo,Phillip Ramila,Wang Flora,Rubio Valerie,Stuge Tor B.,Groshen Susan G.,Gee Conway,Jeffery Georgia G.,Sian Shirley,Lee Peter P.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference72 articles.

1. Tumor antigens recognized by T cells

2. Human tumor antigens for cancer vaccine development

3. A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

4. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidized Melanoma Antigens Promote Activation and Proliferation of Cytotoxic T‐Cell Subpopulations;Advanced Science;2024-07-03

2. Co-formulation of the rF1V plague vaccine with depot-formulated cytokines enhances immunogenicity and efficacy to elicit protective responses against aerosol challenge in mice;Frontiers in Immunology;2024-03-28

3. A new frontier in cancer therapy: The intersection of cancer vaccines and metabolomics;Metabolomics for Personalized Vaccinology;2024

4. Breast Cancer Vaccines: Disappointing or Promising?;Frontiers in Immunology;2022-01-28

5. Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments;Frontiers in Immunology;2021-02-17